Active fragments of angiotensin II: Enzymatic pathways of synthesis and biological effects

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 1, 1997, Pages 28-34

  Ardaillou, Raymond ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II [3-8]; ANGIOTENSIN III;

HUMAN; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; HUMANS; PEPTIDE FRAGMENTS;

EID: 0031045996     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199701000-00006     Document Type: Review

References (73)

1. Erdos EG, Skidgel RA: Renal metabolism of angiotensin I and II. Kidney Int 1990, 38 (suppl 30):524-527.
2. Braam B, Mitchell KD, Fox J, Navar LG: Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1993, 264:F891-F898.
3. Garrison EA, Kadowitz PJ: Analysis of responses to angiotensin I-(3-10) in the hindlimb vascular bed of the cat. Am J Physiol 1996, 270:H1127-H1177.
4. Nanus DM, Engelstein D, Gastl GA, Gluck L, Vidal MJ, Morrison M, Finstal CL, Bander NH, Albino AP: Molecular cloning of the human kidney differentiation antigen gp 160: human aminopeptidase A. Proc Natl Acad Sci USA 1993, 90:7069-7073.
5. Olsen J, Cowell GM, Konigshofer E, Danielsen EM, Moller J, Lausten L, Hansen OC, Welinder KG, Engberg J, Hunziker K et al.: Complete amino-acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett 1988, 238:307-314.
6. Wex T, Lendeckel U, Wex H, Frank K, Ansorge S: Quantification of aminopeptidase N mRNA in T cells by competitive PCR. FEBS Lett 1995, 374:341-344.
7. Ronco P, Antoine M, Baudouin B, Geniteau-Legendre M, Lelongt B, Chatelet F, Verroust P, Vandewalle A: Polarized membrane expression of brush border hydrolases in primary cultures of kidney proximal tubular cells depends on cell differentiation and is induced by dexamethasone. J Cell Physiol 1990, 145:222-237.
8. Troyanovskaya M, Song L, Jayaraman G, Healy DP: Expression of aminopeptidase A, an angiotensinase, in glomerular mesangial cells. Hypertension 1996, 27:518-522. Demonstrates the presence of aminopeptidase A in rat mesangial cells using several approaches: enzymatic activity assay, immunoblot, reverse transcriptase polymerase chain reaction and Northern blot.
9. Stefanovic V, Vlahovic P, Ardaillou N, Ronco P, Ardaillou R: Cell surface aminopeptidase A and N activities in human glomerular epithelial cells. Kidney Int 1992, 41:1571-1580.
10. Giros B, Gros C, Solhonne B, Schwartz JC: Characterization of aminopeptidase responsible for inactivating endogenous Met5 enkephalin in brain slices using peptidase inhibitors and antiaminopeptidase N antibodies. Mol Pharmacol 1986, 29:281-287.
11. Robertson MJ, Cunoosamy MP, Clark KL: Effect of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta. Br J Pharmacol 1992, 106:166-172.
12. Harding JW, Felix D: The effects of aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain. Brain Res 1987, 424:299-304.
13. Ahmad S, Ward PE: Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther 1990, 252:643-650.
14. Chauvel E, Llorens-Cortes C, Coric P, Wilk S, Roques BP, Fournié-Zaluski MC: Differential inhibition of aminopeptidase A and aminopeptidase N by new β aminothiols. J Med Chem 1994, 37:2950-2957.
15. Fournié-Zaluski MC, Coric P, Turcaud S, Bruetschy L, Lucas E, Woble F, Roques BP: Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J Med Chem 1992, 35:1259-1266.
16. Odya CE, Dally RD, Georgiadis KE: Specific high-affinity bradykinin binding by purified porcine kidney post-proline cleaving enzyme. Biochem Pharmacol 1987, 36:39-49.
17. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA: Angiotensin (1-7): a new hormone of the angiotensin system. Hypertension 1991, 18(5 Suppl III):126-133.
18. 125I-Ang II, and nine of their fragments.
19. Wang JM, Baudhuin P, Courtoy PJ, de Potter W: Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture. Endocrinology 1995, 136:5274-5282. Demonstrates that active angiotensin II fragments can be formed within the cells and subsequently released into the medium where they can act in an autocrine or paracrine manner.
20. 1) angiotensin II. Evidence and speculation for its role as an important agonist in the renin-angiotensin system. Circ Res 1975, 36/37:138-148.
21. Trachte GJ, Peach MJ: A potent noncompetitive angiotensin II antagonist induces only competitive inhibition of angiotensin III responses. J Cardiovasc Pharmacol 1983, 5:1025-1033.
22. 7] angiotensin III, a new selective antagonist of the pressor effect of angiotensin III in conscious rats. Life Sci 1988, 43:537-543.
23. Saavedra JM: Brain and pituitary angiotensin. Endocr Rev 1992, 13:329-380.
24. 125I] angiotensin II binding in pig aorta. Eur J Pharmacol 1992, 215:259-264.
25. Sim MK, Yuan HT: Effect of des-Asp angiotensin I on the contractile action of angiotensin II and angiotensin III. Eur J Pharmacol 1995, 28:175-178.
26. 4 and their functions. Regulatory Peptides 1995, 59:269-295. A review of the formation of the Ang metabolites and of their effects in the brain with a particular emphasis on Ang III and Ang IV. The in-vitro and in-vivo studies are discussed. The different types of receptors are characterized.
27. Harding JW, Jensen LL, Hanesworth JM, Roberts KA, Page TA, Wright JW: Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. Am J Physiol 1992, 262:F17-F23.
28. Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JW: Structure-function analyses of brain angiotensin control of pressor actin in rats. Am J Physiol 1989, 257:R1551-R1557.
29. Harding JW, Imboden H, Felix D: Is angiotensin III the centrally active form of angiotensin? [Editorial]. Experientia 1986, 42:706.
30. Wright JW, Harding JW: Regulatory role of brain angiotensins in the control of physiological and behaviorial responses. Brain Res Rev 1992, 17:227-262.
31. Papouchado ML, Vatta MS, Escalada A, Bianchiotti LG, Fernandez BE: Angiotensin II modulates noradrenaline uptake and release in the rat hypothalamus. J Auton Pharmacol 1995, 15:1-8.
32. Vatta MS, Biancotti LG, Locatelli AS, Ponchado ML, Fernandez BE: Monophasic and biphasic effects of angiotensin II and III on norepinephrine uptake and release in rat adrenal medulla. Can J Physiol Pharmacol 1992, 70:821-825.
33. Zini S, Fournié-Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C: Identification of metabolic pathways of brain angiotensin Il and III using specific aminopeptidase inhibitors. Predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 1996, 93:11968-11973. This paper analyses the role of angiotensin III in the control of the release of arginine vasopressin. This analysis utilizes two specific inhibitors acting on aminopeptidases A and N, respectively.
34. Sim MK, Qiu XS: Formation of des-Asp angiotensin I in the hypothalamic extract of normo- and hypertensive rats. Blood Pressure 1994, 3:260-264.
35. Sim MK: Degradation of angiotensin I in the endothelium and smooth muscle in the rat aorta. Biochem Pharmacol 1993, 45:1524-1527.
36. Wright JW, Krebs LT, Stobb JW, Harding JW: The angiotensin IV system: functional implications. Frontiers Neuroendocrinol 1995, 16:23-52.
37. Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, Harding JW: Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regulatory Peptides 1992, 40:409-419.
38. Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL, Harding JW: Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pep 1993, 44:225-232.
39. Hall KE, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW: Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pep 1995, 58:107-115. Results of this study indicate that microvascular endothelial cells are significantly more responsive to basic fibroblast growth factors in the presence of nanomolar concentrations of Ang IV.
40. 4 receptor and attempts to determine its relative molecular mass. It confirms that this receptor is likely not to be linked to a G protein.
41. Wyse B, Greenland K, Sernia C: Specific binding sites for (3-8) angiotensin in C6 glioma cells. Brain Res 1995, 681:41-46. Glioma cells have Ang IV binding sites with properties distinct from those of AT receptors.
42. 4 receptors: specificity and distribution. Kidney Int 1994, 46:1510-1512.
43. Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW: Angiotensin II (3-8) [Ang IV] hippocampal binding: potential role in the facilitation of memory. Brain Res Bull 1993, 32:497-502.
44. Kerins DM, Hao Q, Vaughan DE: Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV. J Clin Invest 1995, 96:2515-2520. This paper indicates that Ang IV is the form of angiotensin that stimulates endothelial expression of the type 1 inhibitor of plasminogen activator. This effect is mediated via a receptor specific for Ang IV.
45. 4 receptor structure-binding relationship: N-terminal modified angiotensin IV analogues. Peptides 1994, 15:1399-1406.
46. Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW: Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther 1993, 266:1036-1042.
47. 2+ channels.
48. 2, in the rat brain and demonstrates that these receptors are differently distributed. It also shows that Ang IV promotes cFos expression.
49. Miller-Wing AV, Hanesworth JM, Sardinia MF, Wright JW, Speth RC, Grove KL, Harding JW: Central angiotensin IV receptors: distribution and specificity in guinea pig brain. J Pharmacol Exp Ther 1993, 266:1718-1726.
50. Cheng DY, De Witt J, Dent EL, Nossaman BD, Kadowitz PJ: Analysis of responses to angiotensin IV in the pulmonary vascular bed of the cat. Eur J Pharmacol 1994, 261:223-227.
51. 1 receptors.
52. Dulin NO, Ernsberger P, Suciu DJ, Douglas JG: Rabbit renal epithelial angiotensin II receptors. Am J Physiol 1994, 267:F776-F782.
53. 4 receptor on a pharmacological basis.
54. 1 [Abstract]. J Am Soc Nephrol 1995, 6:734.
55. Wang L, Eberhard M, Erne P: Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci 1995, 88:557-562. Shows that rabbit cardiac fibroblasts express a specific Ang IV receptor distinct from the known Ang II receptors which mediates the stimulation of cellular DNA and RNA synthesis.
56. Jaiswal N, Diz DI, Chappel MC, Khosla M, Ferrario CM: Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors. Hypertension 1992, 19 (suppl II):49-55.
57. Gironacci MM, Adler-Groschinsky E, Peña C, Enero MA: Effects of angiotensin II and angiotensin (1-7) on the release of [3H] norepinephrine from rat atria. Hypertension 1994, 24:457-460.
58. Garcia NH, Garvin JL: Angiotensin (1-7) has a biphasic effect on fluid absorption in the proximal straight tubule J Am Soc Nephrol 1994, 5:1133-1138.
59. Mahon JM, Carr RD, Nicol AK, Henderson IW: Angiotensin (1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertension 1994, 12:1377-1381.
60. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM: Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin (1-7) heptapeptide. Proc Natl Acad Sci USA 1988, 85:4095-4098.
61. Fontes MAP, Silva LCS, Campagnole-Santos MJ, Khosla MC, Guertzenstein PG, Santos RAS: Evidence that angiotensin (1-7) plays a role in the central control of blood pressure at the ventrolateral medulla acting through specific receptors. Brain Res 1994, 665:175-180.
62. Porsti I, Bara AT, Busse R, Hecker M: Release of nitric oxide by angiotensin (1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol 1994, 111:652-654.
63. Rowe BP, Saylor DL, Speth RC, Absher DR: Angiotensin (1-7) binding at angiotensin II receptors in the rat brain. Regulatory Peptides 1995, 56:139-0-146.
64. Abduhl P, Felix D, Khosla MC: [7-D-Ala]-angiotensin (1-7): selective antagonism of angiotensin (1-7) in the rat paraventricular nucleus. Brain Res Bull 1994, 35:289-291.
65. Felix D, Khosla MC, Imbodem H, Montani B, Ferrario CM: Neurophysiological responses to angiotensin (1-7). Hypertension 1991, 17:1111-1114.
66. (1-7) antagonist produces a diuretic effect.
67. 2 production.
68. 2 receptors.
69. Benter IF, Ferrario CM, Morris M, Diz DI: Antihypertensive actions of angiotensin (1-7) in spontaneously hypertensive rats. Am J Physiol 1995, 269:H313-H319.
70. (1-7) facilitates the baroreceptor reflex, whereas Ang II has the opposite effect.
71. Paula RD, Lima CV, Khosla MC, Santos RAS: Angiotensin (1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 1995, 26:1154-1159.
72. Braszko JJ, Kulakowska A, Wisniewski K: Angiotensin II and its 3-7 fragment improve recognition but not spatial memory in rats. Brain Res Bull 1995, 37:627-631.
73. Matsufuji H, Matsui T, Ohshige S, Kawasaki T, Osajima K, Osajima Y: Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotech Biochem 1995, 59:1398-1401.